[haldujai]

> It costs about $7000 in Europe (the price seems to be similar in different country even though there is no EU wide collective negotiation).

That seems like a monthly price? The treatment regimen in this study is daily for 3 years.

It's hard to find out what drug prices really cost as there are a lot of discounts and negotiations behind the scenes but the best source in this instance would be a cost-effectiveness study which uses local data and happens to be a hot-topic in every national cancer society so is widely available.

EU and US pricing isn't too far off with both being ~130k USD a year give or take.

> it seems to cost ~1500 in India for instance.

There were generics, and there probably still are in parts of the world but they're technically "illegal". AstraZeneca shut down a few and there are pending countersuits against them.

https://www.fiercepharma.com/pharma/astrazeneca-staves-last-...